There is currently no effective therapy for patients with advanced HLRCC-associated papillary renal cell carcinoma. Treatment with bevacizumab and erlotinib resulted in a confirmed response of 72% in ...

Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) is a rare, autosomal dominant syndrome characterised by the development of cutaneous and uterine leiomyomas alongside an aggressive form of ...

From gestures to tech, small accessibility tweaks can make every mile safer and more enjoyable for Deaf athletes ...

Ferroptosis, a regulated cell death mechanism, is emerging as a promising target for cancer therapy. The process is mediated by the activity of acyl-CoA synthetase family member 4 (ACSL4) protein.

Ferroptosis, a regulated cell death mechanism, is emerging as a promising target for cancer therapy. The process is mediated ...